Efficacy and Safety of Ritalin ® LA™, a New, Once Daily, Extended-Release Dosage Form of Methylphenidate, in Children with Attention Deficit Hyperactivity Disorder

By Biederman J.  

Pediatric Drugs, Vol. 5, Iss. 12, 2003-01 ,pp. : 833-841

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Gastrointestinal Tolerability of a Novel Extended-Release Microsphere Formulation of Azithromycin

By Chandra Richa   Liu Ping   Breen Jeanne D.   Fisher Jeannine   Xie Charles   LaBadie Robert   Benner Rebecca J.   Benincosa Lisa J.   Sharma Amarnath  

Clinical Pharmacokinetics, Vol. 46, Iss. 3, 2007-01 ,pp. : 247-259

Adis International

Access to resources Recommend Favorite

A sustained release dosage form of acyclovir for buccal application: An experimental study in dogs

By Değim Tuncer   Eğlen Bilgen   Ocak Ömer  

Journal of Drug Targeting, Vol. 14, Iss. 1, 2006-01 ,pp. : 35-44

Informa Healthcare

Access to resources Recommend Favorite

Effect of Switching Drug Formulations from Immediate-Release to Extended-Release OROS Methylphenidate: A Chart Review of Spanish Adults with Attention-Deficit Hyperactivity Disorder

By Josep Antoni Ramos-Quiroga   Bosch Rosa   Castells Xavier   Valero Sergi   Nogueira Mariana   Gómez Nuria   Yelmo Silvia   Ferrer Marc   Martínez Yolanda   Casas Miguel  

CNS Drugs, Vol. 22, Iss. 7, 2008-01 ,pp. : 603-611

Adis International

Access to resources Recommend Favorite

Extended-release niacin with laropiprant: a review on efficacy, clinical effectiveness and safety

By Yadav Rahul   France Michael   Younis Naveed   Hama Salam   Ammori Basil J   Kwok See   Soran Handrean  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1345-1362

Informa Healthcare

Access to resources Recommend Favorite